A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects

NCT02721589 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: SHR-1210

Sponsor

Jiangsu HengRui Medicine Co., Ltd.